Matthias Bodenstedt holds the role of Chief Financial Officer at MoonLake Immunotherapeutics (MLTX). Bodenstedt has reported 9 insider filings with the SEC since 2025. The most recent filing was in June 2026.
Every role Matthias Bodenstedt has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
MoonLake Immunotherapeutics (MLTX)2 filingsUpdated Aug 30, 2026
Matthias Bodenstedt is Chief Financial Officer of MoonLake Immunotherapeutics (MLTX). 8 SEC Form 4 filings on record going back to 2025, most recently on 23 June 2026. Most recent open-market trade: sold $862K of MLTX on 23 June 2026. Lifetime open-market purchases: $99K. Lifetime open-market sales: $3.20M.
Every recent SEC Form 4 transaction Matthias Bodenstedt has reported, most recent first.
InsiderAlpha's records for Matthias Bodenstedt go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $99K (1 buy totaling $99K). The largest single buy on record is $99K of MLTX in 2025. Sales side: 7 recorded sales totaling $3.20M, so the filing history runs sell-heavy by dollar value. 7 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Insiders who reported open-market trades in the last 12 months at the companies Matthias Bodenstedt files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Matthias Bodenstedt is a corporate insider, tracked as Chief Financial Officer of MoonLake Immunotherapeutics (MLTX). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchase ($99K) and 7 open-market sales ($3.20M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial